المؤلفون: Chanchlani, N, Lin, S, Auth, MK, Lee, CL, Robbins, H, Looi, S, Murugesan, SV, Riley, T, Preston, C, Stephenson, S, Cardozo, W, Sonwalkar, SA, Allah-Ditta, M, Mansfield, L, Durai, D, Baker, M, London, I, London, E, Gupta, S, Di Mambro, A, Murphy, A, Gaynor, E, Jones, KDJ, Claridge, A, Sebastian, S, Ramachandran, S, Selinger, CP, Borg-Bartolo, SP, Knight, P, Sprakes, MB, Burton, J, Kane, P, Lupton, S, Fletcher, A, Gaya, DR, Colbert, R, Seenan, JP, MacDonald, J, Lynch, L, McLachlan, I, Shields, S, Hansen, R, Gervais, L, Jere, M, Akhtar, M, Black, K, Henderson, P, Russell, RK, Lees, CW, Derikx, LAAP, Lockett, M, Betteridge, F, De Silva, A, Hussenbux, A, Beckly, J, Bendall, O, Hart, JW, Thomas, A, Hamilton, B, Gordon, C, Chee, D, McDonald, TJ, Nice, R, Parkinson, M, Gardner-Thorpe, H, Butterworth, JR, Javed, A, Al-Shakhshir, S, Yadagiri, R, Maher, S, Pollok, RCG, Ng, T, Appiahene, P, Donovan, F, Lok, J, Chandy, R, Jagdish, R, Baig, D, Mahmood, Z, Marsh, L, Moss, A, Abdulgader, A, Kitchin, A, Walker, GJ, George, B, Lim, YH, Gulliver, J, Bloom, S, Theaker, H, Carlson, S, Cummings, JRF, Livingstone, R, Beale, A, Carter, JO, Bell, A, Coulter, A, Snook, J, Stone, H, Kennedy, NA, Goodhand, JR

المصدر: Alimentary Pharmacology and Therapeutics (2022) (In press).

مصطلحات موضوعية: adalimumab, anti-TNF, antibodies, drug persistence, immunogenicity, infliximab, therapeutic drug monitoring, treatment failure

وصف الملف: application/pdf

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10155718/1/Implications%20for%20sequencing%20of%20biologic%20therapy.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10155718Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10155718/1/Implications%20for%20sequencing%20of%20biologic%20therapy.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10155718Test/

المؤلفون: Chanchlani, N., Lin, S., Auth, M. K., Lee, C. L., Robbins, H., Looi, S., Murugesan, S. V., Riley, T., Preston, C., Stephenson, S., Cardozo, W., Sonwalkar, S. A., Allah-Ditta, M., Mansfield, L., Durai, D., Baker, M., London, I., London, E., Gupta, S., Di Mambro, A., Murphy, A., Gaynor, E., Jones, K. D. J., Claridge, A., Sebastian, S., Ramachandran, S., Selinger, C. P., Borg-Bartolo, S. P., Knight, P., Sprakes, M. B., Burton, J., Kane, P., Lupton, S., Fletcher, A., Gaya, D. R., Colbert, R., Seenan, J. P., MacDonald, J., Lynch, L., McLachlan, I., Shields, S., Hansen, R., Gervais, L., Jere, M., Akhtar, M., Black, K., Henderson, P., Russell, R. K., Lees, C. W., Derikx, Laap, Lockett, M., Betteridge, F., De Silva, A., Hussenbux, A., Beckly, J., Bendall, O., Hart, J. W., Thomas, A., Hamilton, B., Gordon, C., Chee, D., McDonald, T. J., Nice, R., Parkinson, M., Gardner-Thorpe, H., Butterworth, J. R., Javed, A., Al-Shakhshir, S., Yadagiri, R., Maher, S., Pollok, R. C. G., Ng, T., Appiahene, P., Donovan, F., Lok, J., Chandy, R., Jagdish, R., Baig, D., Mahmood, Z., Marsh, L., Moss, A., Abdulgader, A., Kitchin, A., Walker, G. J., George, B., Lim, Y. H., Gulliver, J., Bloom, S., Theaker, H., Carlson, S., Cummings, J. R. F., Livingstone, R., Beale, A., Carter, J. O., Bell, A., Coulter, A., Snook, J., Stone, H., Kennedy, N. A., Goodhand, J. R., Ahmad, T.

مصطلحات موضوعية: adalimumab, anti-TNF, antibodies, drug persistence, immunogenicity, infliximab, therapeutic drug monitoring, treatment failure

العلاقة: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36039036Test/; Aliment Pharmacol Ther. 2022 Aug 29. doi:10.1111/apt.17170.; https://rde.dspace-express.com/handle/11287/622541Test; Alimentary pharmacology & therapeutics

الإتاحة: https://doi.org/10.1111/apt.17170Test
https://rde.dspace-express.com/handle/11287/622541Test